DCF — NORTHCREST MEDICAL CENTER
Enterprise Value: $-54.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-54.6M
Enterprise Value
$-18.3M
PV of Cash Flows
$-36.3M
PV of Terminal Value
$-58.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $63.6M | $-2.9M | -5.0% | $-5.6M | $-5.0M |
| Year 2 | $65.5M | $-2.3M | -4.0% | $-5.1M | $-4.2M |
| Year 3 | $67.4M | $-1.7M | -3.0% | $-4.5M | $-3.4M |
| Year 4 | $69.5M | $-1.4M | -2.0% | $-4.3M | $-3.0M |
| Year 5 | $71.6M | $-1.3M | -2.0% | $-4.3M | $-2.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-54.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$61.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05000000081009759
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5